Nundina › Discover calendars › FDA New Drug Approvals calendar › FDA approves Bexlutry (lutetium lu-177 dotatate)FDA approves Bexlutry (lutetium lu-177 dotatate)14 September 2026The FDA approved Bexlutry (lutetium lu-177 dotatate), a drug from Curium. Form: Solution, Intravenous. Application NDA218525.FDA New Drug Approvals calendarMore from this calendar

20 October 2026 - FDA approves Hibsago (bepirovirsen)

19 October 2026 - FDA approves Calrezdy (calcuim chloride)

19 October 2026 - FDA approves Cienby (sodium ctirate)

16 October 2026 - FDA approves Yulzety (rivaroxaban)

16 October 2026 - FDA approves Brytly (brytly (apraclonidine))